DePuy Synthes Launches VELYS™ Hip Navigation with AI to Support Intraoperative Consistency and Efficiency in Total Hip Arthroplasty 09 June 2026
DePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstruction Portfolio 26 May 2026
DePuy Synthes Enters Exclusive U.S., Canada and Australia Distribution Agreement for CGBIO’s NOVOSIS 26 May 2026
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium 06 February 2026
Johnson & Johnson Highlights New Scientific Evidence and Reinforces its Leadership with Portfolio Advancements at AF Symposium 03 February 2026
Johnson & Johnson Releases Report on Surgeon Burnout as More than 40% Surveyed Consider Leaving the Profession 03 February 2026
Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile 27 January 2026
Johnson & Johnson Introduces Mobile Simulator App to Support Breast Augmentation Patients 15 January 2026
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration 07 January 2026
Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma 18 December 2025
Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an Eye Exam is the Ultimate Self-Care Move for Women Over 40 03 December 2025
Johnson & Johnson to Spotlight New Evidence in Chronic Subdural Hematoma and Stroke at SVIN 2025 20 November 2025
Johnson & Johnson One Year Data Demonstrate Durable Performance and Safety of the Shockwave Javelin Peripheral IVL Catheter in Late-Breaking Presentation at VIVA 2025 04 November 2025
Johnson & Johnson Confirms Durability of IVL in Complex, Below-the-Knee Anatomy in Late-Breaking Presentation at VIVA 2025 03 November 2025
Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS 03 November 2025
Johnson & Johnson Advances Polyphonic™ AI Fund for Surgery for Data-Driven Healthcare 27 October 2025
Johnson & Johnson MedTech Highlights Newest Impella Heart Pump and Long-Term Survival Data at TCT 2025 24 October 2025
Johnson & Johnson Celebrates a Milestone of 100K TECNIS ODYSSEY IOLs Implanted* at the 2025 American Academy of Ophthalmology Annual Meeting 13 October 2025
Johnson & Johnson Launches INHANCE INTACT™: A Total Shoulder Replacement System Designed for Tissue-Sparing Surgery Providing Day-One Post-Op Mobility 13 October 2025
Johnson & Johnson Initiates CORE-VA Registry to Advance Ventricular Arrhythmia Ablation Care* 10 October 2025
Johnson & Johnson Unveils New Data Demonstrating Superior Clarity of Vision and Comfort of ACUVUE OASYS MAX 1-Day for ASTIGMATISM, and MULTIFOCAL for ASTIGMATISM Contact Lenses 07 October 2025
Johnson & Johnson Announces Launch of its Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions 15 September 2025
Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress 02 September 2025
New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump 31 August 2025
Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions 29 July 2025
Johnson & Johnson Announces Strategic Agreement with Pacira BioSciences to Expand Early Intervention Offering for Osteoarthritis of the Knee 22 July 2025
Johnson & Johnson Marks 25 Years of Neurovascular Care with New Innovation Highlights at SNIS 2025 14 July 2025
Johnson & Johnson Launches VARIPULSE™ Platform across Asia-Pacific, Advancing Atrial Fibrillation Treatment 07 July 2025
Johnson & Johnson Launches the Polyphonic™ AI Fund for Surgery to Advance Data-Driven Healthcare 25 June 2025
Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens1 - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM 23 June 2025
Johnson & Johnson Launches the ETHICON™ 4000 Stapler for Elevated Surgical Experience and the Most Secure Staple Line Yet 10 June 2025
Johnson & Johnson Launches KINCISE™ 2 System, the Only Automated Surgical Impactor Approved for Knee and Hip Revision Procedures 03 June 2025
Johnson & Johnson MedTech Announces New Clinical Data for the MONARCH™ Platform for Robotically-Assisted Bronchoscopy 28 May 2025
Johnson & Johnson MedTech Launches SOUNDSTAR CRYSTAL™ in the US, Redefining Image Clarity in 2D Intracardiac Imaging 21 May 2025
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025 20 May 2025
Shockwave Medical Highlights Commitment to Transform Treatment of Cardiovascular Disease at EuroPCR 2025 15 May 2025
New Breast Implant Closes the Reconstruction Gap for 1 in 7 Women After Breast Cancer Surgery 13 May 2025
Johnson & Johnson MedTech Presents 3-Month Data from Omny-IRE Clinical Trial at 2025 Heart Rhythm Society Annual Meeting 25 April 2025
Johnson & Johnson MedTech to Highlight Advancements in Electrophysiology Innovation with 22 Abstracts at 2025 Heart Rhythm Society Annual Meeting 24 April 2025
Johnson & Johnson MedTech Announces Completion of First Cases with OTTAVA™ Robotic Surgical System 14 April 2025
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform 07 April 2025
Johnson & Johnson Global Survey Reveals Confidence in AI and Medical Technology to Address Personalized Needs of the Aging Population and Alleviate Burnout Among Healthcare Professionals 03 April 2025
Johnson & Johnson MedTech Presents Pivotal 12-Month Effectiveness and Safety Data from SmartfIRE Study at 2025 EHRA Congress 31 March 2025
Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25 27 March 2025
Johnson & Johnson MedTech Launches the DUALTO™ Energy System for Use Across Surgical Treatment Approaches 25 March 2025
Johnson & Johnson MedTech Announces Clearance of MONARCH™ QUEST for Enhanced Robotic-Assisted Bronchoscopy 12 March 2025
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions 04 March 2025
Johnson & Johnson MedTech Celebrates Inaugural National Heart Recovery Awareness Day 20 February 2025
Johnson & Johnson MedTech Launches CEREGLIDE™ 92 Catheter System for Acute Ischemic Stroke 12 February 2025
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter 10 January 2025
Johnson & Johnson MedTech Joins Experts to Define and Classify Surgical Site Outcomes 04 December 2024
MENTOR™ MemoryGel™ Enhance Breast Implant Receives FDA Approval for Largest Size Breast Implants for Reconstruction 02 December 2024
Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions 14 November 2024
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation 07 November 2024
Johnson & Johnson MedTech Unveils New Joint Reconstruction Solutions at 2024 AAHKS Annual Meeting 07 November 2024
Shockwave Medical Further Validates Utility of Intravascular Lithotripsy in Lower Limb Lesions in Late-Breaking Presentation at VIVA 2024 04 November 2024
Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024 04 November 2024
Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF Trial Evaluating Large-Tip, Focal Pulsed Field Ablation OMNYPULSE™ Catheter 30 October 2024
New Data at TCT 2024 Expands on Recently Published New England Journal of Medicine Randomized Controlled Trial Demonstrating a Survival Benefit from Impella® Heart Pumps 24 October 2024
Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting 30 September 2024
ESPN’s Mike Greenbergⁱ Reveals How He Tackled Atrial Fibrillation and Strategically Partners with Johnson & Johnson MedTech to Educate Patients 05 September 2024
DePuy Synthes Launches MatrixSTERNUM™ Fixation System for Enhanced Chest Stability Following Cardiac Surgery 29 August 2024
Biosense Webster Completes Enrollment of Omny-IRE Clinical Trial Investigating the OMNYPULSE™ Large-tip Focal Pulsed Field Ablation Catheter 26 August 2024
Johnson & Johnson MedTech Announces Labeling Amendment of LINX™ Reflux Management System in the U.S. to Include Patients With Barrett’s Esophagus Experiencing Gastroesophageal Reflux Disease 07 August 2024
Johnson & Johnson MedTech Announces the Polyphonic™ Digital Ecosystem for a More Connected Surgical Experience 20 June 2024
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures 06 June 2024
Ethicon Launches ECHELON LINEAR™ Cutter, a First-of-its-Kind Surgical Stapler That Delivered 47% Fewer Leaks at the Staple Line to Help Reduce Surgical Risks 27 May 2024
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting 17 May 2024
Biosense Webster to Present Data from 42 Company-Sponsored or Funded Studies, Including PFA and RF Innovation, at Heart Rhythm Society Annual Meeting 16 May 2024
MEGADYNE™ Initiates Global Discontinuation and Voluntary Recall of MEGA SOFT™ Pediatric Patient Return Electrode 10 May 2024
First Look at Data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH™ SF Platform for Atrial Fibrillation Presented at EHRA Congress 09 April 2024
DePuy Synthes to showcase latest innovations across comprehensive spine portfolio at IMAST 2024 08 April 2024
Randomized Controlled Trial Confirms Impella CP® Improves Survival in Heart Attack with Cardiogenic Shock 07 April 2024
Johnson & Johnson to Showcase its Broad Scientific Leadership and Latest Innovations to Combat Cardiovascular Disease at ACC.24 04 April 2024
CERENOVUS Expands Minimally Invasive Stroke Care Innovation with New Liquid Embolic System Procedural Set 28 March 2024
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation 25 March 2024
Megadyne Reiterates Intended Use Population Change for Megadyne Mega Soft Universal and Universal Plus Patient Return Electrodes 29 February 2024
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE™ Pulsed Field Ablation (PFA) Platform 29 February 2024
Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device 27 February 2024
Orthopaedic Experts Identify Best Practices for Wound Closure and Dressing Management in Total Knee and Total Hip Arthroplasty 12 February 2024
Biosense Webster Supports Collaborative Studies That Aim to Expand Knowledge in Pulsed Field Ablation 08 February 2024
CERENOVUS Launches Next Generation Catheter for Revascularization of Patients with Acute Ischemic Stroke 07 February 2024
Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium 02 February 2024
Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation 01 February 2024
Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in Japan 09 January 2024
Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation 14 December 2023
First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock 27 November 2023
Ethicon Introduces ETHIZIA™ Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding 15 November 2023
New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients 02 November 2023
DePuy Synthes Receives FDA Clearance for TriLEAP™ Lower Extremity Anatomic Plating System 11 October 2023
DePuy Synthes Receives FDA Clearance for the TriALTIS™ Spine System and Navigation Enabled Instruments 09 October 2023
Biosense Webster Study Links Lower Risk of Heart Failure in Atrial Fibrillation Patients Treated with Catheter Ablation Compared to Antiarrhythmic Drugs 05 October 2023
DePuy Synthes is creating increased customer visibility to its supply chain operations 27 September 2023
Ethicon puts customers first by providing greater transparency to its supply chain operations 27 September 2023
Johnson & Johnson Vision Teams Up with Photographer and New York Times Best-Selling Author, Kate T. Parker to Ignite Conversations About Importance of Eye Health 26 September 2023
Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe 18 September 2023
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy 04 August 2023
Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias 24 July 2023
Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe 19 July 2023
Biosense Webster Presents New Data from Pulsed Field Ablation Investigational Studies at Heart Rhythm 2023 19 May 2023
Biosense Webster Showcases Award-Winning Real-World Evidence Demonstrating Value of Catheter Ablation in Driving Improved Patient Outcomes in AFib at Heart Rhythm 2023 19 May 2023
Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI 18 May 2023
New Data Published on Biosense Webster QDOT MICRO™ Catheter – the Latest Advancement in Focal RF Ablation for Treating AFib 15 May 2023
Biosense Webster Highlights New Research and Technology to Advance AFib Treatment at Heart Rhythm 2023 15 May 2023
First Patient Treated in North America with Robot-Assisted Transbronchial Microwave Ablation as part of global Ethicon POWER Study 04 April 2023
Biosense Webster Begins SmartfIRE Clinical Trial to Evaluate its First Dual Energy Catheter to Treat Atrial Fibrillation 07 March 2023
Robotic-Assisted Removal of Kidney Stones for First Patient using MONARCH™ Platform for Urology 07 February 2023
First Look at Data on Biosense Webster’s Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023 03 February 2023
Late Breaking Data on Pulmonary Vein Isolation with HELIOSTAR™ Balloon Ablation Catheter Presented at AF Symposium 2023 03 February 2023
Biosense Webster, Inc. to Highlight Latest Innovations at AF Symposium 2023 Showcasing Breadth of Cardiac Rhythm Portfolio 23 January 2023
CERENOVUS Reveals Positive Outcomes with Thrombectomy in Global Registry Studying Stroke-Inducing Blood Clots 18 November 2022
Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial Fibrillation 10 November 2022
ALTALYNE™ Ultra Alignment System for Adolescent Spinal Deformity Receives FDA Clearance 14 October 2022
Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and At-Risk Population Awareness Gaps 13 September 2022
INHANCE™ Shoulder System from DePuy Synthes Receives FDA 510(k) Clearance for Use in Reverse Total Shoulder Arthroplasty 16 May 2022
Ethicon’s MONARCH® Endoscopic Robotic Platform Receives FDA 510(k) Clearance for Urology Procedures 02 May 2022
First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE™ Catheter for Atrial Fibrillation 29 April 2022
Biosense Webster Showcases Commitment to Patient-centered Innovation at Heart Rhythm 2022 28 April 2022
DePuy Synthes Acquires CUPTIMIZE™ Hip-Spine Analysis, Providing Technology to Help Surgeons Better Understand, Measure and Address Pelvic Tilt 21 March 2022
DePuy Synthes Further Reimagines Knee Restoration with the Addition of Two New Innovations to the ATTUNE™ Knee Portfolio 16 March 2022
CERENOVUS Launches EMBOGUARD™ Balloon Guide Catheter to Use In the Treatment of Acute Ischemic Stroke 07 February 2022
Johnson & Johnson Medical Devices Companies Announces Strategic Partnership with Microsoft to Further Enable its Digital Surgery Solutions 10 January 2022
DePuy Synthes Launches the UNIUM™ System as a Next Generation Power Tools System for Trauma and Small Bone Procedures 22 November 2021
Mentor Launches New MentorDirect Order Management System in the U.S. to Provide Customers With Enhanced Ecommerce Experience 18 August 2021
CERENOVUS Unveils New Data and Showcases Innovations Focused on Changing the Trajectory of Stroke at the Society of NeuroInterventional Surgery 18th Annual Meeting 22 July 2021
CERENOVUS Announces First Patient Enrolled in MEMBRANE Study on Chronic Subdural Hematomas 09 June 2021
DePuy Synthes Launches 2.7 mm Variable Angle Locking Compression Plate Clavicle System Designed to Accommodate Different Shapes and Sizes of the Collarbone 09 June 2021
DePuy Synthes Announces Exclusive Expandable Cage Distribution Agreement with Expanding Innovations Inc. 02 February 2021
JOHNSON & JOHNSON VISION RECEIVES FDA APPROVAL FOR NEXT GENERATION MONOFOCAL INTRAOCULAR LENS - TECNIS EYHANCE™ AND TECNIS EYHANCE™ TORIC II IOLS - FOR THE TREATMENT OF CATARACT PATIENTS 02 February 2021
Auris Health Announces Publication of Results from BENEFIT Study of MONARCH® Platform in CHEST 21 January 2021
DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System 19 January 2021
New CERENOVUS study demonstrates cost-savings associated with First-Pass Effect in mechanical thrombectomy for treating acute ischemic stroke in the US and Europe 08 January 2021
Longest Study of Magnetic Sphincter Augmentation Shows Durable Efficacy of Linx® Reflux Management System 10 November 2020
DePuy Synthes Launches FIBULINK® Syndesmosis Repair System Designed to Enable Precise Tension Control and Physiologic Motion for Patients with Traumatic Ankle Injuries 22 October 2020
DePuy Synthes Launches Radial Head Replacement System with Radiolucent Trials to Improve Visualization and Sizing 21 October 2020
Biosense Webster Receives FDA Approval for THERMOCOOL SMARTTOUCH® SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation 06 October 2020
First Patients in Europe Treated with Biosense Webster VARIPULSE® Catheter for Atrial Fibrillation Treatment 01 October 2020
Ethicon Launches Novel, Easy-to-use Staple Line Reinforcement Device for Bariatric, Thoracic and General Surgery 15 September 2020
Returning To Clinical Practice Amid COVID-19: How Healthcare Professionals and Health Systems Can Address Patient Concerns 03 September 2020
Biosense Webster Launches CARTO® 3 System Version 7 and the CARTO PRIME® Mapping Module to Advance Treatment of Complex Arrhythmias 27 August 2020
Break a Bone Badly? You Could Be a Candidate for This Innovative 3-D Printed Medical Device 16 July 2020
Caring on the COVID-19 Front Lines: "I Took a Leave From My Job to Treat Some of the Sickest Patients in an ICU" 22 June 2020
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc. 20 December 2019
Creating a System of Connected Technologies to Transform the Future of Orthopaedic Surgery through VELYS™ Digital Surgery 09 December 2019
New Cervical Spine System from DePuy Synthes Advances Treatment Options for Patients with Complex Cervical Spine Disorders 21 November 2019
